Interleukin 2 in Cancer Therapy
Keywords: (Eastern Coopera-tive Oncology Group Scale; (IL-2); (IL-2R); Cancer Therapy; HIGH DOSE IL-2; IL-2 therapy; Interferon; Interferon-alpha; Interleukin-2; Metastatic Melanoma; Phase II clinical trial; Phase III clinical trial; Renal Cell Cancer; T-cells; TNF alpha and beta; anemia; biochemotherapy (BCT); cardiac stress test; cell carcinoma; chills; confusion; diarrhea; eosinophilia; eosinophilic myocarditis; erythroderma; fever; hepatic enzymes elevation; immunotherapy; inhibitors; kidney cancer; lethargy; lymphopenia; malig-nant melanoma; malignant melanoma; melanoma; metastatic kidney cancer; nausea; phosphorylation; renal cell carcinoma; thrombocytopenia; transient fever; tumor infiltrating lymphocytes (TILs); tyrosine kinase
Document Type: Research Article
Publication date: 01 October 2010
- Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews written by leaders in the field covering a range of the current topics in medicinal chemistry. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.